Comparative Cost‐Effectiveness of Interventions to Improve Medication Adherence after Myocardial Infarction
- 21 September 2012
- journal article
- research article
- Published by Wiley in Health Services Research
- Vol. 47 (6) , 2097-2117
Abstract
Objective: To evaluate the comparative cost‐effectiveness of interventions to improve adherence to evidence‐based medications among postmyocardial infarction (MI) patients.Data Sources/Study Setting: Cost‐effectiveness analysis.Study Design: We developed aMarkov model simulating a hypothetical cohort of 65‐year‐old post‐MIpatients who were prescribed secondary prevention medications. We evaluated mailed education, disease management, polypill use, and combinations of these interventions. The analysis was performed from a societal perspective over a lifetime horizon. The main outcome was an incremental cost‐effectiveness ratio (ICER) as measured by cost per quality‐adjusted life year (QALY) gained.Data Collection/Extraction Methods: Model inputs were extracted from published literature.Principal Findings: Compared with usual care, only mailed education had both improved health outcomes and reduced spending. Mailed education plus disease management, disease management, polypill use, polypill use plus mailed education, and polypill use plus disease management cost were $74,600, $69,200, $133,000, $113,000, and $142,900 perQALYgained, respectively. In an incremental analysis, only mailed education had anICERof less than $100,000 perQALYand was therefore the optimal strategy. Polypill use, particularly when combined with mailed education, could be cost effective, and potentially cost saving if its price decreased to less than $100 per month.Conclusions: Mailed education and a polypill, once available, may be the cost‐saving strategies for improving post‐MImedication adherence.Keywords
This publication has 43 references indexed in Scilit:
- The Fixed-dose Combination Drug for Secondary Cardiovascular Prevention project: Improving equitable access and adherence to secondary cardiovascular prevention with a fixed-dose combination drug. Study design and objectivesAmerican Heart Journal, 2011
- Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effectsAmerican Heart Journal, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Physician Effectiveness in Interventions to Improve Cardiovascular Medication Adherence: A Systematic ReviewJournal of General Internal Medicine, 2010
- Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patientsPharmacoepidemiology and Drug Safety, 2008
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare BeneficiariesCirculation, 2008
- Impact of Stroke on Health-Related Quality of Life in the Noninstitutionalized Population in the United StatesStroke, 2006
- National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insuranceAmerican Heart Journal, 2006
- Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysisThe Lancet, 2006